Podrobno

Poštne storitve in varnost poštnih pošiljk : diplomsko delo visokošolskega programa
ID Valentan, Jože (Avtor), ID Debelak, Slavko (Mentor) Več o mentorju... Povezava se odpre v novem oknu

.pdfPDF - Predstavitvena datoteka, prenos (991,04 KB)
MD5: 58641ED109A2835156E5126A2CA87B82
PID: 20.500.12556/rul/2f4c2749-a0ac-477a-916c-49134f35a719

Jezik:Slovenski jezik
Ključne besede:pošta, storitve, poštni promet, pisma, poštne pošiljke, diplomske naloge
Vrsta gradiva:Diplomsko delo
Tipologija:2.11 - Diplomsko delo
Organizacija:FU - Fakulteta za upravo
Kraj izida:Ljubljana
Založnik:[J. Valentan]
Leto izida:2009
Št. strani:V, 61 str.
PID:20.500.12556/RUL-2251 Povezava se odpre v novem oknu
UDK:656.8(043.2)
COBISS.SI-ID:3193518 Povezava se odpre v novem oknu
Datum objave v RUL:11.07.2014
Število ogledov:5163
Število prenosov:538
Metapodatki:XML DC-XML DC-RDF
:
VALENTAN, Jože, 2009, Poštne storitve in varnost poštnih pošiljk : diplomsko delo visokošolskega programa [na spletu]. Diplomsko delo. Ljubljana : J. Valentan. [Dostopano 7 junij 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=2251
Kopiraj citat
Objavi na:Bookmark and Share

Podobna dela

Podobna dela v RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Podobna dela v drugih slovenskih zbirkah:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Nazaj